European Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Hospitals by Country

In 2023, Malta had the highest expenditure on pharmaceuticals and medical non-durable goods by hospitals, standing at 7.36% of total health expenditure. Italy followed at 3.09%, while the Netherlands and Portugal were the lowest at 0.11% and 0.02%, respectively. Notable year-on-year variations in 2023 included a significant increase in Malta by 10.54% and a decrease in Slovenia by 9.5%. Lithuania experienced robust growth at 12.2%, indicating strong investment in healthcare goods. The CAGR for these countries over the last five years points towards a modest average annual change, with Malta consistently showing upward growth.

Future trends to observe include an expected increase in digital health investments, impacting how medical non-durable goods are used. Countries like Malta, showing strong growth rates, may continue expanding their healthcare infrastructure, potentially influencing pharmaceutical expenditure. Watch for technological advancements and policy changes that might alter spending patterns across Europe.